In various cancers, tumor-derived ligands (e.g., CD24 and sialoglycans) induce monocyte differentiation toward protumor TAM phenotype by Siglec-7, Siglec-9, Siglec-10, Siglec-15, and Siglec-E [287, 305–311]. Here, CD24 is linked to cancer.